Page last updated: 2024-08-23

epirubicin and Uveal Neoplasms

epirubicin has been researched along with Uveal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dorval, T; Lantz, O; Louis, D; Milder, M; Péguillet, I; Piperno-Neumann, S; Scholl, SM; Vincent-Salomon, A	1

Other Studies

1 other study(ies) available for epirubicin and Uveal Neoplasms

Article	Year
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer research, 2014, Apr-15, Volume: 74, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Lymphocytes; Cell Differentiation; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Leukapheresis; Melanoma; Neoadjuvant Therapy; T-Lymphocyte Subsets; Taxoids; Uveal Neoplasms	2014

Article

Year

High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.

Cancer research, 2014, Apr-15, Volume: 74, Issue:8

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Lymphocytes; Cell Differentiation; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Leukapheresis; Melanoma; Neoadjuvant Therapy; T-Lymphocyte Subsets; Taxoids; Uveal Neoplasms

2014